Literature DB >> 11571489

Renal vascular effects of frusemide in the rat: influence of salt loading and the role of angiotensin II.

L Dobrowolski1, B Badzyńska, M Grzelec-Mojzesowicz, J Sadowski.   

Abstract

We showed recently that post-frusemide (furosemide) natriuresis was associated with a major depression of medullary circulation. In the present study, prior to administration of frusemide the tubular transport of NaCl was modified by loading the animals with 5% saline to elucidate a possible interrelation between the tubular and vascular effects of the drug. Moreover, a possible involvement of the renin-angiotensin system was examined by pharmacological blockade using captopril, an inhibitor of angiotensin converting enzyme (1 mg x kg(-1), I.V.), or losartan, a selective inhibitor of angiotensin AT1 receptor (10 mg x kg(-1), I.V.). The effects of frusemide (0.25 mg x kg(-1) I.V., then the same dose given over 1 h) on renal medullary and cortical circulation (using laser-Doppler flowmetry) and renal excretion of sodium (U(Na)V), water and total solutes were measured in anaesthetised rats. With no pre-treatment, frusemide decreased the medullary flow (36.6 +/- 6.0%) significantly more than the cortical flow (10.1 +/- 1.0%; P < 0.001). The difference between the medulla and cortex was not significant in rats which showed high U(Na)V after hypertonic saline loading (2.0 +/- 0.4 vs. 0.4 +/- 0.1 micromol x min(-1) in non-loaded rats): 21.1 +/- 3.9% and 15.8 +/- 1.5%, respectively. At very high U(Na)V (9.5 +/- 1.1 micromol x min(-1)) the post-frusemide decrease in blood flow tended to be smaller in the medulla (7.6 +/- 7.7%) than in the cortex (16.2 +/- 2.6%). The fall in medullary blood flow was attenuated by pre-treatment with captopril (22.0 +/- 3.3%) and abolished by pre-treatment with losartan (2.8 +/- 11.8%). The decrease in cortical blood flow was not changed by hypertonic saline or angiotensin II blockers. The abolition of the post-frusemide depression of medullary blood flow by previous salt loading confirms the proposed link between tubular transport status and vasoconstriction. A similar modification of the response by blockade of the renin-angiotensin system suggests that the system is involved in the mechanism of medullary vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11571489     DOI: 10.1113/eph8602219

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  6 in total

1.  Furosemide-induced renal medullary hypoperfusion in the rat: role of tissue tonicity, prostaglandins and angiotensin II.

Authors:  Leszek Dobrowolski; Janusz Sadowski
Journal:  J Physiol       Date:  2005-06-16       Impact factor: 5.182

2.  Antimicrobial therapy with aminoglycoside or meropenem in the intensive care unit for hospital associated infections and risk factors for acute kidney injury.

Authors:  Raphael Donadio Pitta; Juliano Gasparetto; Thyago Proença De Moraes; João Paulo Telles; Felipe Francisco Tuon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-12       Impact factor: 3.267

3.  Furosemide is associated with acute kidney injury in critically ill patients.

Authors:  T M Levi; M S Rocha; D N Almeida; R T C Martins; M G C Silva; N C P Santana; I T Sanjuan; C M S Cruz
Journal:  Braz J Med Biol Res       Date:  2012-05-31       Impact factor: 2.590

4.  Human renal response to furosemide: Simultaneous oxygenation and perfusion measurements in cortex and medulla.

Authors:  Bryan Haddock; Henrik B W Larsson; Susan Francis; Ulrik B Andersen
Journal:  Acta Physiol (Oxf)       Date:  2019-05-21       Impact factor: 6.311

5.  New renal haemodynamic indices can predict worsening of renal function in acute decompensated heart failure.

Authors:  Amir Mostafa; Karim Said; Walid Ammar; Ahmed Elsayed Eltawil; Magdy Abdelhamid
Journal:  ESC Heart Fail       Date:  2020-06-30

6.  Loop Diuretics Are Associated with Increased Risk of Hospital-Acquired Acute Kidney Injury in Adult Patients: A Retrospective Study.

Authors:  Liping Zhou; Yanqin Li; Qi Gao; Yuxin Lin; Licong Su; Ruixuan Chen; Yue Cao; Ruqi Xu; Fan Luo; Peiyan Gao; Xiaodong Zhang; Pingping Li; Sheng Nie; Ying Tang; Xin Xu
Journal:  J Clin Med       Date:  2022-06-24       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.